Achilles Therapeutics : SAE Cell and Gene Therapy 2023 - Targeting Clonal Neoantigens in Cancer
Targeting Clonal Neoantigens in Cancer SAE Media Group Cell and Gene Therapy - 20 June 2023 Sergio Quezada, Chief Scientific Officer, Achilles Therapeutics ...
Source: marketscreener.com